Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.299 Q1 | 103 | 177 | 379 | 22198 | 2240 | 363 | 4.96 | 125.41 | 44.80 | |
2 | Current Medicinal Chemistry | journal | 0.759 Q2 | 202 | 229 | 1117 | 25841 | 4143 | 1046 | 3.54 | 112.84 | 45.47 | |
3 | Mini-Reviews in Medicinal Chemistry | journal | 0.597 Q2 | 107 | 128 | 492 | 14236 | 1903 | 484 | 3.60 | 111.22 | 43.35 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 0.620 Q2 | 96 | 120 | 223 | 12672 | 632 | 207 | 2.79 | 105.60 | 41.97 | |
5 | Current Drug Targets | journal | 0.691 Q2 | 119 | 97 | 390 | 10001 | 1214 | 368 | 2.96 | 103.10 | 43.82 | |
6 | Current Molecular Pharmacology | journal | 0.540 Q3 | 49 | 72 | 209 | 6446 | 509 | 199 | 2.37 | 89.53 | 43.73 | |
7 | Current Pharmaceutical Design | journal | 0.586 Q2 | 183 | 316 | 1278 | 27228 | 3460 | 1174 | 2.55 | 86.16 | 44.50 | |
8 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.361 Q3 | 27 | 23 | 93 | 1583 | 149 | 88 | 1.15 | 68.83 | 60.40 | |
9 | Current Cancer Drug Targets | journal | 0.650 Q2 | 103 | 76 | 216 | 5127 | 602 | 211 | 2.34 | 67.46 | 40.55 | |
10 | Trends in Phytochemical Research | journal | 0.290 Q3 | 8 | 18 | 73 | 1149 | 109 | 67 | 1.82 | 63.83 | 52.27 | |
11 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.503 Q3 | 108 | 201 | 723 | 12531 | 2011 | 702 | 2.69 | 62.34 | 40.91 | |
12 | Anti-Infective Agents | journal | 0.178 Q4 | 26 | 38 | 152 | 2338 | 114 | 146 | 0.61 | 61.53 | 44.62 | |
13 | Current Vascular Pharmacology | journal | 0.991 Q1 | 69 | 47 | 196 | 2887 | 702 | 154 | 2.23 | 61.43 | 41.86 | |
14 | Current Radiopharmaceuticals | journal | 0.542 Q3 | 32 | 35 | 103 | 1937 | 170 | 92 | 1.29 | 55.34 | 43.71 | |
15 | Open Medicinal Chemistry Journal | journal | 0.289 Q3 | 23 | 9 | 22 | 476 | 47 | 19 | 2.80 | 52.89 | 36.36 | |
16 | Current Pharmacogenomics and Personalized Medicine | journal | 0.127 Q4 | 20 | 12 | 49 | 613 | 9 | 42 | 0.08 | 51.08 | 54.55 | |
17 | Physiology and Pharmacology (Iran) | journal | 0.148 Q4 | 15 | 40 | 117 | 2032 | 49 | 114 | 0.40 | 50.80 | 55.11 | |
18 | Journal of Medicinal Plants | journal | 0.209 Q4 | 27 | 22 | 162 | 1080 | 158 | 161 | 1.23 | 49.09 | 40.23 | |
19 | Infectious Disorders - Drug Targets | journal | 0.338 Q3 | 61 | 89 | 374 | 4320 | 542 | 350 | 1.47 | 48.54 | 42.90 | |
20 | Journal of Toxicology | journal | 0.564 Q3 | 47 | 25 | 101 | 1152 | 363 | 101 | 3.83 | 46.08 | 45.00 | |
21 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.138 Q4 | 10 | 100 | 175 | 4597 | 64 | 175 | 0.35 | 45.97 | 51.01 | |
22 | Ankara Universitesi Eczacilik Fakultesi Dergisi | journal | 0.153 Q4 | 13 | 100 | 185 | 4022 | 112 | 185 | 0.49 | 40.22 | 63.77 | |
23 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.356 Q3 | 43 | 24 | 64 | 958 | 90 | 56 | 1.28 | 39.92 | 43.10 | |
24 | Records of Natural Products | journal | 0.392 Q3 | 41 | 100 | 184 | 3912 | 437 | 183 | 2.44 | 39.12 | 45.40 | |
25 | Reviews on Recent Clinical Trials | journal | 0.331 Q3 | 35 | 36 | 139 | 1393 | 184 | 123 | 1.51 | 38.69 | 42.86 | |
26 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.258 Q3 | 45 | 31 | 108 | 1193 | 98 | 103 | 0.85 | 38.48 | 37.50 | |
27 | Current Drug Safety | journal | 0.352 Q3 | 41 | 83 | 127 | 2789 | 177 | 124 | 1.10 | 33.60 | 45.66 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®